Zema Lucia, Palugan Luca, Maroni Alessandra, Foppoli Anastasia, Sangalli Maria Edvige, Gazzaniga Andrea
Istituto di Chimica Farmaceutica e Tossicologica "P. Pratesi", Università degli Studi di Milano, viale Abruzzi 42, 20131 Milan, Italy.
AAPS PharmSciTech. 2008;9(2):708-17. doi: 10.1208/s12249-008-9106-0. Epub 2008 Jun 4.
It has recently been highlighted that the release behavior of pellets containing microcystalline cellulose (MCC) as the spheronizing agent may be impaired by the lack of disintegration. Although alternative spheronizing excipients have been proposed, their overall advantages have not thoroughly been assessed. In the present work, the possible use of beta-cyclodextrin (betaCD) was therefore explored for the manufacturing of pellets with a potential for effective disintegration and immediate release of poorly soluble active ingredients. MCC/betaCD powder formulations containing no drug or model drugs with different water solubility, able to form inclusion compounds with the employed cyclodextrin, were pelletized by agglomeration in rotary fluid bed equipment. By applying successive statistical experimental designs, the most critical formulation and operating parameters were identified and optimal manufacturing processes were ultimately set up. High yields of pellets provided with satisfactory physical-technological characteristics were obtained using powder formulations with up to 80% betaCD. Based on dissolution testing results, the suitability of betaCD for the preparation of disintegrating MCC-containing pellets with improved dissolution performance was finally demonstrated.
最近有研究强调,以微晶纤维素(MCC)作为滚圆剂的微丸,其释放行为可能会因缺乏崩解性而受到影响。尽管已经提出了替代滚圆辅料,但它们的总体优势尚未得到充分评估。因此,在本研究中,探讨了β-环糊精(βCD)在制备具有有效崩解潜力且能立即释放难溶性活性成分的微丸中的可能应用。不含药物或含有不同水溶性模型药物(能够与所用环糊精形成包合物)的MCC/βCD粉末制剂,通过在旋转流化床设备中团聚造粒。通过应用连续的统计实验设计,确定了最关键的制剂和操作参数,并最终建立了最佳生产工艺。使用βCD含量高达80%的粉末制剂,可获得具有令人满意的物理技术特性的高产率微丸。基于溶出度测试结果,最终证明了βCD适用于制备具有改善溶出性能的含MCC崩解微丸。